Malaysia Among First In SEA To Conduct Covid-19 Seroprevalence Study
This can tell us how many people in Malaysia may have been previously infected with Covid-19.
Subscribe to our new Telegram channel for the latest updates on COVID-19 and other issues.
Malaysia is going to be one of the first countries in Southeast Asia to conduct the Covid-19 seroprevalence study. The study will comprehensively determine the level of Covid-19 infection in the country.
What you need to know: According to Health deputy director-general (Research and Technical Support) Dr Hishamshah Mohd Ibrahim, the study falls under the scope of the National Health and Morbidity Survey (NHMS) this year.
A seroprevalence study essentially examines the prevalence of the Covid-19 virus in the serologic (blood) samples of the community.
Why it matters: While the current test being used to determine Covid-19 positive status uses samples collected from nasal swabs, blood tests are a more comprehensive level of testing, which can provide information about possible past infections as well.
The findings of the seroprevalence study can provide a more accurate estimate of the Covid-19 infection at the community level in Malaysia which may have not been reported as most of the infections are asymptomatic or have mild and non-specific symptoms.
Therefore, respondents taking part in the study will also be able to find out their Covid-19 infection status.
What’s next: The seroprevalence samples will be collected together with the NHMS by the Public Health Institute from 2 August to 7 October and involve around 5,000 respondents from 2,000 residences selected randomly nationwide.
Malaysia among first in SE Asia to conduct Covid-19 seroprevalence study, says Health deputy D-G (Malay Mail)
What COVID-19 Seroprevalence Surveys Can Tell Us (United States CDC)
For more updates on Covid-19, follow us on Facebook, Twitter and Instagram!
Starving forensic investigator turned writer cause she couldn't find a job. Used to search for killers now searches for killer stories.